Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 3 minute read Pharma Industry News AbbVie and Genmab’s TEPKINLY approved by EC for advanced lymphoma AbbVie (NYSE: ABBV) and Genmab (NASDAQ: GMAB) have announced that the European Commission (EC) has granted conditional marketing… byPallavi MadhirajuAugust 20, 2024